Literature DB >> 23958737

CYP2D6 genotyping and the use of tamoxifen in breast cancer.

Donald Berry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23958737     DOI： 10.1093/jnci/djt221

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Breast cancer recurrence in relation to antidepressant use.

Authors:  Jessica Chubak; Erin J A Bowles; Onchee Yu; Diana S M Buist; Monica Fujii; Denise M Boudreau
Journal:  Cancer Causes Control       Date:  2015-10-30       Impact factor: 2.506

2.  CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer - a reply.

Authors:  Hiltrud Brauch; Matthias Schwab
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

3.  CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer.

Authors:  Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

4.  Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer.

Authors:  Michael A Province; Teri E Klein
Journal:  J Natl Cancer Inst       Date:  2014-01-09       Impact factor: 13.506

5.  Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

Authors:  Matthew P Goetz; Hiltrud Brauch; Mark J Ratain; Nancy J Cox; Yusuke Nakamura; Richard Weinshilboum; James N Ingle
Journal:  J Natl Cancer Inst       Date:  2014-04-03       Impact factor: 13.506

Review 6.  CYP2D6 genotype and tamoxifen: considerations for proper nonprospective studies.

Authors:  M P Goetz; J N Ingle
Journal:  Clin Pharmacol Ther       Date:  2014-08       Impact factor: 6.875

Review 7.  Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen.

Authors:  Aurelia H M de Vries Schultink; Wilbert Zwart; Sabine C Linn; Jos H Beijnen; Alwin D R Huitema
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.